Literature DB >> 12672810

How does Pseudomonas fluorescens avoid suicide from its antibiotic pseudomonic acid?: Evidence for two evolutionarily distinct isoleucyl-tRNA synthetases conferring self-defense.

Tatsuo Yanagisawa1, Makoto Kawakami.   

Abstract

Two isoleucyl-tRNA synthetases (IleRSs) encoded by two distinct genes (ileS1 and ileS2) were identified in pseudomonic acid (mupirocin)-producing Pseudomonas fluorescens. The most striking difference between the two IleRSs (IleRS-R1 and IleRS-R2) is the difference in their abilities to resist pseudomonic acid. Purified IleRS-R2 showed no sensitivity to pseudomonic acid even at a concentration of 5 mm, 105 times higher than the Ki value of IleRS-R1. The amino acid sequence of IleRS-R2 exhibits eukaryotic features that are originally found in eukaryotic proteins. Escherichia coli cells transformed with the ileS2 gene exerted pseudomonic acid resistance more than did those transformed with ileS1. Cells transformed with both genes became almost as resistant as P. fluorescens. These results suggest that the presence of IleRS-R2 could be the major reason why P. fluorescens is intrinsically resistant to the antibiotic. Here we suggest that the evolutionary scenario of the eukaryotic ileS2 gene can be explained by gene acquisition and that the pseudomonic acid producer may have maintained the ileS2 gene to protect itself from pseudomonic acid.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12672810     DOI: 10.1074/jbc.M302633200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Insights into physiological and genetic mupirocin susceptibility in bifidobacteria.

Authors:  Fausta Serafini; Francesca Bottacini; Alice Viappiani; Enrico Baruffini; Francesca Turroni; Elena Foroni; Tiziana Lodi; Douwe van Sinderen; Marco Ventura
Journal:  Appl Environ Microbiol       Date:  2011-03-18       Impact factor: 4.792

Review 2.  Prospects for aminoacyl-tRNA synthetase inhibitors as new antimicrobial agents.

Authors:  Julian Gregston Hurdle; Alexander John O'Neill; Ian Chopra
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

Review 3.  Recent advances in the chemistry and biology of naturally occurring antibiotics.

Authors:  K C Nicolaou; Jason S Chen; David J Edmonds; Anthony A Estrada
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

Review 4.  Biased gene transfer in microbial evolution.

Authors:  Cheryl P Andam; J Peter Gogarten
Journal:  Nat Rev Microbiol       Date:  2011-06-13       Impact factor: 60.633

5.  Recent developments in self-resistance gene directed natural product discovery.

Authors:  Yan Yan; Nicholas Liu; Yi Tang
Journal:  Nat Prod Rep       Date:  2020-01-08       Impact factor: 13.423

Review 6.  Comparison of Strategies to Overcome Drug Resistance: Learning from Various Kingdoms.

Authors:  Hiroshi Ogawara
Journal:  Molecules       Date:  2018-06-18       Impact factor: 4.411

Review 7.  Resistance to and synthesis of the antibiotic mupirocin.

Authors:  Christopher M Thomas; Joanne Hothersall; Christine L Willis; Thomas J Simpson
Journal:  Nat Rev Microbiol       Date:  2010-03-01       Impact factor: 60.633

8.  Mechanisms of resistance to an amino acid antibiotic that targets translation.

Authors:  Sandro F Ataide; Sharnise N Wilson; Sandy Dang; Theresa E Rogers; Bappaditya Roy; Rajat Banerjee; Tina M Henkin; Michael Ibba
Journal:  ACS Chem Biol       Date:  2007-12-21       Impact factor: 5.100

9.  A novel tryptophanyl-tRNA synthetase gene confers high-level resistance to indolmycin.

Authors:  James J Vecchione; Jason K Sello
Journal:  Antimicrob Agents Chemother       Date:  2009-06-22       Impact factor: 5.191

10.  Nonorthologous replacement of lysyl-tRNA synthetase prevents addition of lysine analogues to the genetic code.

Authors:  Brian C Jester; Jeffrey D Levengood; Hervé Roy; Michael Ibba; Kevin M Devine
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.